Blockade of CD40L is effective in ameliorating experimental autoimmune conditions, and it has also been suggested as a potential therapeutic strategy for MS.129 Also, FCRL3 is mainly expressed in B cells, and it has been linked to multiple autoimmune conditions.130. Here, FCRL3 is linked to myeloid sarcoma.